Skip to content

Effect of 'Mobile APP' on Comprehensive Intervention of Traditional Chinese medicine in Patients with Impaired Glucose Regulation

Effect of 'Mobile APP' on Comprehensive Intervention of Traditional Chinese medicine in Patients with Impaired Glucose Regulation

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800014856
Enrollment
Unknown
Registered
2018-02-09
Start date
2018-03-17
Completion date
Unknown
Last updated
2018-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired Glucose Regulation

Interventions

APP:diet, exercise, TCM intervention by APP
control group:diet, exercise, TCM intervention

Sponsors

Shanghai Changhai Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 59 Years

Inclusion criteria

Inclusion criteria: 1. Patients with IGR (Standards of WHO1999): 6mmol/L =< Fasting blood glucose =< 7mmol/L 2h Postprandial blood glucose (75 grams OGGT) =< 7.8mmol/L; Fasting blood glucose =< 6.1mmol/L, 7.8mmol/L =< 2h Postprandial blood glucose =< 11.1mmol/L; 6mmol/L =< Fasting blood glucose =< 7mmol/L, 7.8mmol/L =< 2h Postprandial blood glucose =< 11.1mmol/L; 2. Male or femaleaged from 40 to 59 years old; 3. To be able to use the smart phone mobile APP and microphone mobile client; 4. The patients sign the information consent form.

Exclusion criteria

Exclusion criteria: 1. Newly diagnosed type 2 diabetes mellitus; 2. Previously diagnosed type 1 or 2 diabetes mellitus; 3. Patients with obvious hepatic (obvious clinical symptoms or signs of liver disease, acute or chronic hepatitis, 4. AST and ALT > 2 folds of the upper limits of normal range respectively); 5. Patients with obvious renal disease (Creatinine > 1.2 folds of the upper limit of normal range,=1.5 mg/dL(133 µmol/L,male)=1.4mg/dL(124 µmol/L,female)or eGFR<45ml/min/1.73m2; 6. Severe chronic gastrointestinal disease; 7. Any blood disease that may affect HbA1c measurements(Hemolytic anemia, sickle cell disease); 8. Combined with cortisol hyperthyroidism, hyperthyroidism, chronic liver disease and other diseases affecting glucose metabolism and pregnancy, cancer, psychosis.

Design outcomes

Primary

MeasureTime frame
BMI;Waist circumference;Hip circumference;Waist and hip ratio;blood pressure;blood glucose;Glycated hemoglobin;TCM Syndrome Investigation;Chinese medicine physique scale;blood insulin;

Secondary

MeasureTime frame
sports survey;dietary survey;

Countries

China

Contacts

Public ContactWang Lin

Shanghai Changhai Hospital

wanglin1210@163.com+86 021-81871574

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026